Free Trial
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel Free OXBR Stock Alerts

Oxbridge Re (OXBR) Financials

Oxbridge Re logo
$1.00 +0.07 (+7.94%)
Closing price 10/16/2026 03:56 PM Eastern
Extended Trading
$0.98 -0.03 (-2.50%)
As of 10/16/2026 06:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Oxbridge Re

Annual Income Statements for Oxbridge Re

This table shows Oxbridge Re's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 4.00 4.60 2.58 -21 -5.75 -0.31 -0.10 -1.79 -9.92 -2.73 -2.08
Consolidated Net Income / (Loss)		 4.00 4.60 2.58 -21 -5.75 -0.31 -0.10 -1.79 -9.37 -2.59 -2.08
Net Income / (Loss) Continuing Operations		 4.00 4.60 2.58 -21 -7.75 -0.15 0.04 -1.75 -9.37 -2.59 -2.08
Total Pre-Tax Income 		4.00 4.60 2.58 -21 -7.75 -0.15 0.09 -1.75 -9.37 -2.59 -2.08
Total Revenue		 5.56 6.38 19 24 3.81 0.88 1.21 0.85 -7.05 0.55 2.58
Net Interest Income / (Expense)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income		 5.56 6.38 19 24 3.81 0.88 1.16 0.85 -7.05 0.55 2.58
Other Service Charges		 - - - - - - - 0.00 0.30 0.31 0.00
Net Realized & Unrealized Capital Gains on Investments		 0.74 -0.39 1.00 0.27 1.11 0.23 0.43 0.19 -8.64 -1.81 0.33
Premiums Earned		 11 15 17 22 2.95 0.62 0.89 1.00 1.26 2.30 2.29
Other Non-Interest Income		 -5.77 -8.29 0.88 1.34 -0.25 0.03 -0.16 -0.34 0.04 -0.26 -0.04
Total Non-Interest Expense		 1.56 1.78 16 44 12 1.03 1.13 2.60 2.32 2.17 6.04
Property & Liability Insurance Claims		 - 0.00 15 42 10 - - 1.07 - 0.00 2.74
Insurance Policy Acquisition Costs		 0.43 0.34 0.29 0.68 0.26 0.06 0.10 0.11 0.14 0.25 0.25
Other Operating Expenses		 1.13 1.44 1.42 1.33 1.28 0.96 1.03 1.41 2.18 1.92 3.05
Nonoperating Income / (Expense), net		 - - - - - - - - - -0.96 1.39
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - - - - - 0.04 0.00 0.14 0.00
Basic Earnings per Share		 $0.82 $0.76 $0.43 ($3.55) ($1.00) ($0.05) ($0.01) ($0.31) ($1.69) ($0.45) ($0.28)
Weighted Average Basic Shares Outstanding		 4.86M 6.06M 6.02M 5.81M 5.73M 5.73M 5.73M 5.77M 5.87M 6.10M 7.39M
Diluted Earnings per Share		 $0.82 $0.76 $0.43 ($3.55) ($1.00) ($0.05) - ($0.31) ($1.69) ($0.45) ($0.28)
Weighted Average Diluted Shares Outstanding		 4.86M 6.06M 6.02M 5.81M 5.73M 5.73M 5.73M 5.77M 5.87M 6.10M 7.39M
Weighted Average Basic & Diluted Shares Outstanding		 4.86M 6.06M 6.02M 5.81M 5.73M 5.73M 5.73M 5.87M 5.87M 7.44M 7.80M

Quarterly Income Statements for Oxbridge Re

This table shows Oxbridge Re's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -2.67 -0.91 -0.82 -0.54 -0.46 -0.14 -1.87 -0.19 0.12 0.02 0.18
Consolidated Net Income / (Loss)		 -2.13 -0.91 -0.82 -0.54 -0.32 -0.13 -2.00 -0.17 0.22 0.04 0.29
Net Income / (Loss) Continuing Operations		 -2.44 -0.91 -0.82 -0.54 -0.32 -0.13 -2.00 -0.17 0.22 0.04 0.29
Total Pre-Tax Income 		-2.44 -0.91 -0.82 -0.54 -0.32 -0.13 -2.00 -0.17 0.22 0.04 0.29
Total Revenue		 -1.91 -0.13 0.04 0.21 0.42 0.69 0.66 0.65 0.58 0.62 0.94
Net Interest Income / (Expense)		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Interest Income		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Interest Expense		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Non-Interest Income		 -1.91 -0.13 0.04 0.21 0.42 0.69 0.66 0.65 0.58 0.62 0.94
Other Service Charges		 - - 0.31 0.00 - - 0.00 0.00 - - 0.50
Net Realized & Unrealized Capital Gains on Investments		 -2.50 -0.59 -0.76 -0.36 -0.10 0.09 0.09 0.08 0.06 0.07 0.07
Premiums Earned		 0.52 0.55 0.56 0.60 0.60 0.60 0.58 0.56 0.56 0.56 0.37
Other Non-Interest Income		 0.07 -0.09 -0.07 -0.03 -0.07 0.00 -0.01 0.01 -0.04 0.00 0.00
Total Non-Interest Expense		 0.54 0.78 0.63 0.50 0.27 0.82 3.61 0.82 0.79 0.59 0.65
Salaries and Employee Benefits		 - - - - - - 1.26 - - - 0.60
Property & Liability Insurance Claims		 - - 0.00 0.00 - - 2.29 0.00 - - 0.00
Insurance Policy Acquisition Costs		 0.06 0.06 0.06 0.07 0.07 0.07 0.06 0.06 0.06 0.06 0.04
Nonoperating Income / (Expense), net		 - - -0.24 -0.25 - - 0.95 -0.00 - - -0.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.31 0.00 0.00 0.00 0.14 0.01 -0.13 0.02 0.10 0.02 0.12
Basic Earnings per Share		 ($0.46) ($0.15) ($0.14) ($0.09) ($0.07) ($0.02) ($0.25) ($0.02) $0.01 $0.00 $0.02
Weighted Average Basic Shares Outstanding		 5.87M 6.01M 6.01M 6.12M 6.10M 6.90M 7.44M 7.66M 7.39M 7.80M 8.10M
Diluted Earnings per Share		 ($0.46) ($0.15) ($0.14) ($0.09) ($0.07) ($0.02) ($0.25) ($0.02) $0.01 $0.00 $0.02
Weighted Average Diluted Shares Outstanding		 5.87M 6.01M 6.01M 6.12M 6.10M 6.90M 7.44M 7.66M 7.39M 7.80M 8.10M
Weighted Average Basic & Diluted Shares Outstanding		 5.87M 6.01M 6.04M 6.23M 7.44M 7.44M 7.54M 7.68M 7.80M 8.10M 8.14M

Annual Cash Flow Statements for Oxbridge Re

This table details how cash moves in and out of Oxbridge Re's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 4.62 3.27 3.66 -25 0.41 -3.28 -0.44 -1.49 -0.18 2.15 1.08
Net Cash From Operating Activities		 8.68 8.13 0.37 -26 -6.63 -4.37 -0.27 -0.83 -1.26 -0.28 -1.35
Net Cash From Continuing Operating Activities		 8.68 8.13 0.42 -26 -6.63 -4.37 -0.17 -0.83 -1.26 -0.28 -1.35
Net Income / (Loss) Continuing Operations		 4.00 4.60 2.58 -21 -5.75 -0.31 0.05 -1.79 -9.92 -2.73 -2.08
Consolidated Net Income / (Loss)		 4.00 4.60 2.58 -21 -5.75 -0.31 0.05 -1.79 -9.92 -2.73 -2.08
Depreciation Expense		 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.00 0.01 0.00 0.00
Non-Cash Adjustments to Reconcile Net Income		 -0.22 0.84 -0.44 0.65 -1.98 0.01 -0.19 0.47 8.87 2.38 0.44
Changes in Operating Assets and Liabilities, net		 4.89 2.67 -1.77 -6.48 1.07 -4.08 -0.04 0.48 -0.22 0.06 0.29
Net Cash From Investing Activities		 -29 -1.95 6.87 4.67 5.05 0.49 0.11 -0.66 -0.11 0.78 0.12
Net Cash From Continuing Investing Activities		 -29 -1.95 6.87 4.67 5.05 0.49 0.11 -0.66 -0.11 0.78 0.12
Purchase of Property, Leasehold Improvements and Equipment		 -0.06 -0.04 -0.01 -0.01 0.00 -0.00 -0.01 0.00 -0.01 0.00 -0.02
Sale and/or Maturity of Investments		 8.01 13 20 27 16 0.99 2.72 0.63 0.00 0.78 0.14
Net Cash From Financing Activities		 25 -2.91 -3.63 -3.15 2.00 0.60 -0.38 0.00 1.18 1.65 2.31
Net Cash From Continuing Financing Activities		 25 -2.91 -3.63 -3.15 2.00 0.60 -0.38 0.00 1.18 1.65 2.31
Issuance of Debt		 - - - 0.00 2.00 0.60 0.22 0.00 1.28 1.47 0.00
Issuance of Common Equity		 0.01 - - - - - - - 0.00 1.13 3.53
Other Financing Activities, Net		 27 - - - - - -0.00 - - -0.95 -1.21

Quarterly Cash Flow Statements for Oxbridge Re

This table details how cash moves in and out of Oxbridge Re's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 0.10 0.57 -0.33 0.84 1.07 3.70 -2.94 0.52 -0.20 1.21 12
Net Cash From Operating Activities		 0.10 -0.28 -0.04 0.26 -0.23 0.27 -2.17 0.12 0.43 0.21 -0.27
Net Cash From Continuing Operating Activities		 0.10 -0.28 -0.04 0.26 -0.23 0.27 -2.17 0.12 0.43 0.21 -0.27
Net Income / (Loss) Continuing Operations		 -2.67 -0.91 -0.82 -0.54 -0.46 -0.14 -1.87 -0.19 0.12 0.02 0.18
Consolidated Net Income / (Loss)		 -2.67 -0.91 -0.82 -0.54 -0.46 -0.14 -1.87 -0.19 0.12 0.02 0.18
Depreciation Expense		 0.00 0.00 - 0.00 - 0.00 - - 0.00 0.00 0.00
Non-Cash Adjustments to Reconcile Net Income		 2.55 0.80 0.63 0.52 0.43 0.13 0.00 0.18 0.15 0.06 -0.37
Changes in Operating Assets and Liabilities, net		 0.22 -0.17 0.16 0.27 -0.20 0.28 -0.30 0.12 0.16 0.13 -0.08
Net Cash From Financing Activities		 - 0.40 -0.29 0.58 0.97 3.37 -0.77 0.41 -0.69 1.00 12
Net Cash From Continuing Financing Activities		 - 0.40 -0.29 0.58 0.97 3.37 -0.77 0.41 -0.69 1.00 12
Issuance of Debt		 - 0.40 1.07 - - 3.12 -0.25 - - 1.00 -0.96
Other Financing Activities, Net		 - - - - - 0.25 - - - 0.00 6.32

Annual Balance Sheets for Oxbridge Re

This table presents Oxbridge Re's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 50 53 51 21 13 9.50 9.08 17 8.25 7.47 8.05
Cash and Due from Banks		 5.32 8.58 12 7.76 8.07 5.96 5.56 1.21 0.50 2.14 0.27
Restricted Cash		 28 30 23 3.12 3.23 2.05 1.91 2.72 3.25 3.76 6.71
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Loans and Leases		 - - - - - - - - - - 0.00
Premises and Equipment, Net		 0.05 0.06 0.05 0.04 0.02 0.01 0.01 0.01 0.00 0.00 0.02
Unearned Premiums Asset		 4.08 4.12 4.04 3.80 0.00 0.51 0.46 0.28 0.98 1.06 0.77
Deferred Acquisition Cost		 0.13 0.09 0.09 0.05 0.00 0.05 0.05 0.13 0.10 0.11 0.10
Other Assets		 0.08 0.09 0.10 0.12 0.07 0.21 0.30 12 2.68 0.29 0.19
Total Liabilities & Shareholders' Equity		 50 53 51 21 13 9.50 9.08 17 8.25 7.47 8.05
Total Liabilities		 13 16 14 7.48 4.25 1.45 1.06 1.63 2.92 1.62 1.56
Short-Term Debt		 - - - - - - - - - - 0.12
Long-Term Debt		 - - - - 0.00 0.60 0.22 0.22 0.12 0.12 0.00
Claims and Claim Expense		 - 0.00 8.70 4.84 4.11 - - 1.07 - 0.00 0.09
Unearned Premiums Liability		 5.74 5.57 3.46 2.01 0.00 0.44 0.41 0.00 0.92 0.99 0.93
Other Long-Term Liabilities		 7.24 10 1.67 0.63 0.14 0.41 0.43 0.34 1.89 0.51 0.43
Redeemable Noncontrolling Interest		 - - - - - - - - - 1.73 0.52
Total Equity & Noncontrolling Interests		 37 37 37 14 8.31 8.04 8.03 15 5.33 4.11 5.98
Total Preferred & Common Equity		 37 37 37 14 8.31 8.04 8.03 15 5.33 3.95 5.92
Total Common Equity		 37 37 37 14 8.31 8.04 8.03 15 5.33 3.95 5.92
Common Stock		 34 34 33 32 32 32 32 32 33 34 38
Retained Earnings		 3.15 4.84 4.53 -18 -24 -24 -24 -17 -27 -30 -32
Noncontrolling Interest		 - - - - - - - - 0.00 0.16 0.06

Quarterly Balance Sheets for Oxbridge Re

This table presents Oxbridge Re's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 7.26 7.82 7.32 10 9.17 8.85 8.74 20
Cash and Due from Banks		 0.53 3.59 1.41 4.96 3.87 0.73 0.89 4.11
Restricted Cash		 3.78 0.39 3.41 4.63 2.78 6.45 7.30 16
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Loans and Leases		 - - - - - - - 0.00
Premises and Equipment, Net		 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.01
Unearned Premiums Asset		 0.49 2.12 1.37 0.22 1.98 1.21 0.23 0.31
Deferred Acquisition Cost		 0.05 0.24 0.18 0.04 0.22 0.16 0.04 0.04
Other Assets		 2.06 1.20 0.71 0.28 0.21 0.19 0.26 0.19
Total Liabilities & Shareholders' Equity		 7.26 7.82 7.32 10 9.17 8.85 8.74 20
Total Liabilities		 2.76 4.04 3.67 1.07 2.69 1.98 2.12 1.02
Short-Term Debt		 - - - - - - 0.12 0.12
Long-Term Debt		 0.12 0.12 0.12 0.12 0.12 0.12 1.00 0.03
Claims and Claim Expense		 - - - - 0.18 0.00 0.09 0.09
Unearned Premiums Liability		 0.37 2.18 1.59 0.40 2.04 1.48 0.37 0.32
Other Long-Term Liabilities		 2.28 1.74 1.97 0.55 0.36 0.38 0.54 0.46
Redeemable Noncontrolling Interest		 - - - 1.98 1.21 1.21 0.52 13
Total Equity & Noncontrolling Interests		 4.50 3.79 3.65 7.22 5.28 5.67 6.10 6.77
Total Preferred & Common Equity		 4.50 3.79 3.65 7.04 5.34 5.71 6.02 6.59
Total Common Equity		 4.50 3.79 3.65 7.04 5.34 5.71 6.02 6.59
Common Stock		 33 33 33 37 37 38 38 39
Retained Earnings		 -28 -29 -30 -30 -32 -32 -32 -32
Noncontrolling Interest		 - - - 0.18 -0.06 -0.04 0.08 0.19

Annual Metrics And Ratios for Oxbridge Re

This table displays calculated financial ratios and metrics derived from Oxbridge Re's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 6,000,000.00 6,060,000.00 5,960,324.00 5,733,587.00 5,733,587.00 5,733,587.00 5,733,587.00 5,781,587.00 5,870,234.00 6,226,259.00 7,676,122.00
DEI Adjusted Shares Outstanding		 6,000,000.00 6,060,000.00 5,960,324.00 5,733,587.00 5,733,587.00 5,733,587.00 5,733,587.00 5,781,587.00 5,870,234.00 6,226,259.00 7,676,122.00
DEI Earnings Per Adjusted Shares Outstanding		 0.67 0.76 0.43 -3.59 -1.00 -0.05 -0.02 -0.31 -1.60 -0.42 -0.27
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 14.77% 198.78% 25.07% -84.02% -77.03% 38.74% 0.00% -929.29% 107.75% 371.98%
EBITDA Growth		 0.00% 15.10% -43.21% -880.94% 62.33% 98.19% 170.00% 0.00% -437.72% 82.68% -113.44%
EBIT Growth		 0.00% 15.03% -43.90% -897.83% 62.41% 98.06% 158.67% 0.00% -436.83% 82.66% -113.11%
NOPAT Growth		 0.00% 15.03% -43.90% -658.48% 62.37% 98.06% 183.81% 0.00% -436.83% 82.66% -113.11%
Net Income Growth		 0.00% 15.03% -43.90% -897.83% 72.08% 94.69% 67.21% 0.00% -423.92% 72.40% 19.64%
EPS Growth		 0.00% -7.32% -43.42% -925.58% 71.83% 95.00% 0.00% 0.00% -445.16% 73.37% 37.78%
Operating Cash Flow Growth		 0.00% -6.37% -95.40% -7,134.76% 74.79% 34.10% 93.91% 0.00% -51.99% 77.46% -374.65%
Free Cash Flow Firm Growth		 0.00% 0.00% -42.90% 261.17% -97.97% -341.51% 212.90% 0.00% 0.00% -151.58% -86.65%
Invested Capital Growth		 0.00% 0.87% 0.37% -62.55% -40.26% 3.96% -4.65% 0.00% -64.16% 9.36% 10.92%
Revenue Q/Q Growth		 0.00% -16.85% 135.45% -32.76% 65.08% -61.86% 19.37% 0.00% -71.88% 130.66% 6.36%
EBITDA Q/Q Growth		 0.00% -22.17% -50.44% 10.08% -852.05% 98.45% 653.85% 0.00% -49.92% 61.55% -12.11%
EBIT Q/Q Growth		 0.00% -22.27% -51.03% 10.02% -891.51% 98.34% 2,833.33% 0.00% -49.87% 61.51% -12.14%
NOPAT Q/Q Growth		 0.00% -22.27% -51.03% 10.02% -654.63% 98.34% 2,833.33% 0.00% -49.87% 65.47% -108.61%
Net Income Q/Q Growth		 0.00% -22.27% -51.04% 10.03% -942.96% 95.53% 41.18% 0.00% -42.77% 41.15% -25.24%
EPS Q/Q Growth		 0.00% -16.48% -51.14% 9.90% -869.23% 95.80% 0.00% 0.00% 0.00% 46.43% 22.22%
Operating Cash Flow Q/Q Growth		 0.00% 6.89% -89.69% -646.38% 74.33% 50.65% -26.67% 0.00% 16.17% -760.47% 54.46%
Free Cash Flow Firm Q/Q Growth		 0.00% -14.26% 74.15% -16.14% 109.88% -123.78% -6.67% -100.00% -68.43% 76.67% 29.87%
Invested Capital Q/Q Growth		 2.89% 1.16% -8.17% -0.01% -50.26% 0.82% 2.36% 4.89% 0.00% 58.13% -5.45%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 72.19% 72.40% 13.76% -85.92% -202.52% -16.00% 8.07% -204.94% 0.00% -297.07% -134.34%
EBIT Margin		 71.96% 72.12% 13.54% -86.37% -203.18% -17.14% 7.25% -205.41% 0.00% -297.62% -134.38%
Profit (Net Income) Margin		 71.96% 72.12% 13.54% -86.37% -150.89% -34.86% -8.24% -210.47% 0.00% -473.81% -80.68%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 74.19% 203.33% -113.64% 102.46% 100.00% 100.00% 100.10%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.10% 100.00% 100.00% 100.00% 100.00% 159.20% 59.98%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 10.90% 12.48% 6.96% -56.44% -48.80% -1.24% 1.04% -8.04% 0.00% -19.94% -38.57%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% -67.91% -45.04% -270.45% 0.00% -1,248.33% 253.89%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% -2.49% -2.29% -3.90% 0.00% -26.37% 4.86%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 0.00% 0.00% -3.73% -1.24% -11.94% -92.25% -46.30% -33.71%
Cash Return on Invested Capital (CROIC)		 0.00% 11.61% 6.59% 34.57% 1.62% -5.12% 5.80% 0.00% 30.93% -28.88% -48.92%
Operating Return on Assets (OROA)		 13.10% 8.99% 4.98% -56.89% -45.60% -1.36% 0.95% -10.51% 0.00% -20.68% -44.63%
Return on Assets (ROA)		 13.10% 8.99% 4.98% -56.89% -33.86% -2.77% -1.08% -10.77% 0.00% -32.92% -26.79%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 0.00% 0.00% -3.73% -1.24% -11.94% -92.25% -38.46% -26.96%
Return on Equity Simple (ROE_SIMPLE)		 10.90% 12.43% 6.95% -147.95% -69.15% -3.79% -1.25% -11.94% -175.79% -65.53% -35.14%
Net Operating Profit after Tax (NOPAT)		 4.00 4.60 2.58 -14 -5.42 -0.11 0.09 -1.22 -6.56 -1.14 -2.42
NOPAT Margin		 71.96% 72.12% 13.54% -60.46% -142.37% -12.00% 7.25% -143.79% 0.00% -208.33% -94.07%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 66.67% 46.08% 262.41% 1,683.77% 1,228.39% -292.46%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 28.04% 27.88% 86.46% 186.37% 303.18% 117.14% 92.75% 305.41% 0.00% 397.62% 234.38%
Earnings before Interest and Taxes (EBIT)		 4.00 4.60 2.58 -21 -7.74 -0.15 0.09 -1.75 -9.37 -1.63 -3.46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 4.01 4.62 2.62 -20 -7.72 -0.14 0.10 -1.74 -9.37 -1.62 -3.46
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.76 0.80 0.90 0.89 0.43 0.53 1.34 0.46 1.21 6.50 1.71
Price to Tangible Book Value (P/TBV)		 0.76 0.80 0.90 0.89 0.43 0.53 1.34 0.46 1.21 6.50 1.71
Price to Revenue (P/Rev)		 5.01 4.65 1.76 0.52 0.95 4.88 8.83 8.16 0.00 46.99 3.93
Price to Earnings (P/E)		 6.96 6.45 13.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 5.17% 9.80% 8.52% 22.33% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 14.37% 15.49% 7.69% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.10 0.00 0.00 0.42 0.21 0.52 3.65 0.58
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.06 0.00 0.00 2.85 3.80 0.00 39.88 1.49
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 35.32 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 39.34 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 39.34 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.16 0.00 0.00 7.06 0.00 0.89 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.07 0.03 0.01 0.02 0.02 0.02
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.07 0.03 0.01 0.02 0.02 0.00
Financial Leverage		 0.00 0.00 0.00 0.00 0.00 0.04 0.05 0.01 0.02 0.02 0.02
Leverage Ratio		 1.38 1.39 1.40 1.42 1.53 1.35 1.16 1.11 1.22 1.41 1.26
Compound Leverage Factor		 1.38 1.39 1.40 1.42 1.53 1.35 1.16 1.11 1.22 2.24 0.75
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 6.94% 2.62% 1.42% 2.17% 1.98% 1.78%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.78%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 6.94% 2.62% 1.42% 2.17% 1.98% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 31.78% 8.73%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 93.06% 97.38% 98.58% 97.83% 66.24% 89.49%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -4.29 2.20 -0.12 -0.01 -0.07 -0.03
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 52.97 -74.08 2.13 0.39 3.56 1.98
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -4.29 2.20 -0.12 -0.01 -0.07 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -5.71 2.45 -0.18 -0.02 -0.10 -0.05
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 70.63 -82.50 3.04 0.55 5.08 2.83
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -5.71 2.45 -0.18 -0.02 -0.10 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.95% 20.03%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 4.28 2.45 8.83 0.18 -0.43 0.49 0.00 3.19 -1.65 -3.08
Operating Cash Flow to CapEx		 14,710.17% 22,572.22% 3,400.00% -438,500.00% 0.00% -437,100.00% -1,900.00% 0.00% -25,200.00% 0.00% -8,425.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.18 0.12 0.37 0.66 0.22 0.08 0.13 0.05 0.00 0.07 0.33
Fixed Asset Turnover		 0.00 116.00 323.08 529.80 141.11 64.81 110.36 170.00 0.00 218.40 303.18
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 37 37 37 14 8.31 8.64 8.24 15 5.45 5.96 6.61
Invested Capital Turnover		 0.15 0.17 0.51 0.93 0.34 0.10 0.14 0.06 0.00 0.10 0.41
Increase / (Decrease) in Invested Capital		 0.00 0.32 0.14 -23 -5.60 0.33 -0.40 0.00 -9.76 0.51 0.65
Enterprise Value (EV)		 -5.65 -9.26 -2.10 1.44 -7.69 -3.14 3.46 3.23 2.83 22 3.85
Market Capitalization		 28 30 34 12 3.61 4.27 11 6.94 6.46 26 10
Book Value per Share		 $6.12 $6.11 $6.24 $2.43 $1.45 $1.40 $1.40 $2.59 $0.91 $0.63 $0.77
Tangible Book Value per Share		 $6.12 $6.11 $6.24 $2.43 $1.45 $1.40 $1.40 $2.59 $0.91 $0.63 $0.77
Total Capital		 37 37 37 14 8.31 8.64 8.24 15 5.45 5.96 6.61
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.60 0.22 0.22 0.12 0.12 0.12
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.60 0.22 0.22 0.12 0.12 0.00
Net Debt		 -33 -39 -36 -11 -11 -7.42 -7.26 -3.71 -3.63 -5.78 -6.86
Capital Expenditures (CapEx)		 0.06 0.04 0.01 0.01 0.00 0.00 0.01 0.00 0.01 0.00 0.02
Net Nonoperating Expense (NNE)		 0.00 0.00 0.00 6.18 0.32 0.20 0.19 0.57 2.81 1.45 -0.35
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 0.00 0.00 0.60 0.22 0.22 0.12 0.12 0.12
Total Depreciation and Amortization (D&A)		 0.01 0.02 0.04 0.11 0.03 0.01 0.01 0.00 0.01 0.00 0.00
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.82 $0.76 $0.43 ($3.55) ($1.00) ($0.05) ($0.01) $0.00 ($1.69) ($0.45) ($0.28)
Adjusted Weighted Average Basic Shares Outstanding		 6.06M 6.06M 5.89M 5.73M 5.73M 5.73M 5.73M 0.00 5.87M 6.10M 7.39M
Adjusted Diluted Earnings per Share		 $0.82 $0.76 $0.43 ($3.55) ($1.00) ($0.05) ($0.01) $0.00 ($1.69) ($0.45) ($0.28)
Adjusted Weighted Average Diluted Shares Outstanding		 6.06M 6.06M 5.89M 5.73M 5.73M 5.73M 5.73M 0.00 5.87M 6.10M 7.39M
Adjusted Basic & Diluted Earnings per Share		 $0.82 $0.76 $0.43 $0.00 $0.00 $0.00 ($0.01) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 4.86M 6.06M 5.89M 5.81M 5.73M 5.73M 5.73M 0.00 5.87M 7.44M 7.80M
Normalized Net Operating Profit after Tax (NOPAT)		 2.80 3.22 1.81 -14 -5.42 -0.11 0.06 -1.22 -6.56 -1.14 -2.42
Normalized NOPAT Margin		 50.37% 50.48% 9.48% -60.46% -142.37% -12.00% 5.07% -143.79% 0.00% -208.33% -94.07%
Pre Tax Income Margin		 71.96% 72.12% 13.54% -86.37% -203.39% -17.14% 7.25% -205.41% 0.00% -473.81% -80.60%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 42.70% 63.20% 111.78% -10.15% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 42.70% 63.20% 140.53% -15.31% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Oxbridge Re

This table displays calculated financial ratios and metrics derived from Oxbridge Re's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 5,870,234.00 5,870,234.00 6,006,661.00 6,036,579.00 6,226,259.00 7,442,922.00 7,442,922.00 7,535,922.00 7,676,122.00 7,801,374.00 8,101,374.00
DEI Adjusted Shares Outstanding		 5,870,234.00 5,870,234.00 6,006,661.00 6,036,579.00 6,226,259.00 7,442,922.00 7,442,922.00 7,535,922.00 7,676,122.00 7,801,374.00 8,101,374.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.36 -0.15 -0.14 -0.09 -0.05 -0.02 -0.27 -0.02 0.03 0.00 0.04
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -282.65% -122.89% -93.63% 103.21% 122.15% 653.60% 1,409.09% 214.63% 36.49% -9.97% 41.57%
EBITDA Growth		 -458.68% -727.08% -11,580.00% 95.87% 106.44% 86.16% -405.14% 41.78% -238.22% 131.20% 109.97%
EBIT Growth		 -459.35% -737.32% -9,633.33% 95.86% 106.43% 86.19% -405.14% 41.98% -238.85% 130.40% 109.93%
NOPAT Growth		 -351.55% -546.13% -9,633.33% 95.86% 86.84% 86.19% -405.14% 41.98% 199.69% 143.43% 114.19%
Net Income Growth		 -414.16% -737.32% -865.88% 92.60% 84.93% 86.19% -144.09% 68.15% 169.16% 130.40% 114.57%
EPS Growth		 0.00% -850.00% -1,300.00% 92.74% 84.78% 86.67% -78.57% 77.78% 114.29% 100.00% 108.00%
Operating Cash Flow Growth		 165.31% -97.14% 97.63% 0.00% -340.63% 198.55% -6,102.86% -54.26% 287.45% -22.79% 87.70%
Free Cash Flow Firm Growth		 0.00% 679.22% 715.54% -141.62% -109.13% -147.32% -143.48% 15.91% 41.88% 133.81% -164.49%
Invested Capital Growth		 -64.16% -69.94% -74.43% 0.00% 9.36% 101.69% 69.14% 85.51% 10.92% -16.96% 195.25%
Revenue Q/Q Growth		 70.15% 93.44% 135.20% 365.91% 105.85% 63.98% -4.05% -2.86% -10.70% 8.16% 50.88%
EBITDA Q/Q Growth		 65.49% 62.98% 35.33% 50.00% 153.77% -179.62% -2,260.00% 94.24% -27.65% 117.97% 653.85%
EBIT Q/Q Growth		 65.48% 62.91% 35.47% 49.83% 153.58% -179.62% -2,260.00% 94.24% -28.24% 117.43% 671.05%
NOPAT Q/Q Growth		 65.48% 62.91% 35.47% 49.83% -9.56% 61.06% -2,260.00% 94.24% 288.24% -83.04% 671.05%
Net Income Q/Q Growth		 70.82% 57.51% 9.28% 34.23% 40.56% 61.06% -1,503.20% 91.42% 229.07% -82.88% 668.42%
EPS Q/Q Growth		 62.90% 67.39% 6.67% 35.71% 22.22% 71.43% -1,150.00% 92.00% 150.00% -100.00% 0.00%
Operating Cash Flow Q/Q Growth		 -62.79% -387.50% 87.32% 837.14% -189.53% 217.75% -898.16% 105.44% 266.95% -51.50% -227.14%
Free Cash Flow Firm Q/Q Growth		 -15.72% 25.59% 8.44% -136.26% 81.51% -550.95% 0.37% 29.86% 87.22% 478.69% -879.41%
Invested Capital Q/Q Growth		 0.00% -15.28% -15.42% -3.48% 58.13% 56.24% -29.07% 5.86% -5.45% 16.97% 152.18%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 0.00% 0.00% -1,327.27% -142.44% 37.20% -18.06% -444.28% -26.36% -37.67% 6.26% 31.28%
EBIT Margin		 0.00% 0.00% -1,327.27% -142.93% 37.20% -18.06% -444.28% -26.36% -37.85% 6.10% 31.17%
Profit (Net Income) Margin		 0.00% 0.00% -1,865.91% -263.41% -76.07% -18.06% -301.81% -26.67% 38.54% 6.10% 31.06%
Tax Burden Percent		 87.30% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 99.11% 100.00% 100.00%
Interest Burden Percent		 100.00% 100.00% 140.58% 184.30% -204.46% 100.00% 67.93% 101.18% -102.75% 100.00% 99.66%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% -5.10% -2.47% -117.36% -8.31% 15.94% 1.80% 6.65%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% -86.71% -34.25% -65.66% -53.22% 14.25% 1.80% 5.90%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% -1.83% -0.59% -1.51% -1.19% 0.27% 0.14% 0.06%
Return on Equity (ROE)		 -92.25% -105.87% -117.79% -120.41% -6.93% -3.07% -118.86% -9.50% 16.22% 1.94% 6.71%
Cash Return on Invested Capital (CROIC)		 30.93% 34.50% 36.54% -374.81% -28.88% -85.58% -78.39% -81.50% -48.92% 2.81% -95.87%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 2.58% -2.81% -103.68% -7.90% -12.57% 1.61% 5.87%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% -5.28% -2.81% -70.43% -7.99% 12.80% 1.61% 5.85%
Return on Common Equity (ROCE)		 -92.25% -105.87% -117.79% -120.41% -5.75% -2.58% -105.59% -8.45% 12.97% 1.60% 3.10%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -231.61% -294.59% -120.41% 0.00% -25.67% -37.98% -29.07% 0.00% -31.83% 5.77%
Net Operating Profit after Tax (NOPAT)		 -1.71 -0.63 -0.41 -0.21 -0.22 -0.09 -2.07 -0.12 0.22 0.04 0.29
NOPAT Margin		 0.00% 0.00% -929.09% -100.05% -53.25% -12.64% -310.99% -18.45% 38.89% 6.10% 31.17%
Net Nonoperating Expense Percent (NNEP)		 252.69% 187.24% 349.32% 567.63% 81.61% 31.78% -51.69% 44.92% 1.69% 0.00% 0.75%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 64.15%
Operating Expenses to Revenue		 0.00% 0.00% 1,427.27% 242.93% 62.80% 118.06% 544.28% 126.36% 137.85% 93.90% 68.83%
Earnings before Interest and Taxes (EBIT)		 -2.44 -0.91 -0.58 -0.29 0.16 -0.13 -2.95 -0.17 -0.22 0.04 0.29
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -2.44 -0.90 -0.58 -0.29 0.16 -0.13 -2.95 -0.17 -0.22 0.04 0.29
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.21 1.38 3.78 4.60 6.50 2.00 2.43 2.36 1.71 1.53 1.27
Price to Tangible Book Value (P/TBV)		 1.21 1.38 3.78 4.60 6.50 2.00 2.43 2.36 1.71 1.53 1.27
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 46.99 10.32 6.53 5.57 3.93 3.67 3.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 64.69
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.55%
Enterprise Value to Invested Capital (EV/IC)		 0.52 0.44 2.67 3.20 3.65 0.72 1.15 1.09 0.58 0.35 0.07
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 39.88 4.95 3.81 3.13 1.49 1.09 0.52
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.76
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 242.53 280.90 0.00 25.54 0.00 0.00 0.00 0.00 2.91
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.89 0.59 2.98 0.00 0.00 0.00 0.00 0.00 0.00 11.42 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.02 0.03 0.03 0.03 0.02 0.01 0.02 0.02 0.02 0.17 0.01
Long-Term Debt to Equity		 0.02 0.03 0.03 0.03 0.02 0.01 0.02 0.02 0.00 0.15 0.00
Financial Leverage		 0.02 0.01 0.01 0.03 0.02 0.02 0.02 0.02 0.02 0.08 0.01
Leverage Ratio		 1.22 1.22 1.40 2.01 1.41 1.28 1.65 1.54 1.26 1.20 1.14
Compound Leverage Factor		 1.22 1.22 1.97 3.70 -2.88 1.28 1.12 1.56 -1.29 1.20 1.14
Debt to Total Capital		 2.17% 2.56% 3.02% 3.13% 1.98% 1.27% 1.79% 1.69% 1.78% 14.46% 0.76%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.78% 1.53% 0.61%
Long-Term Debt to Total Capital		 2.17% 2.56% 3.02% 3.13% 1.98% 1.27% 1.79% 1.69% 0.00% 12.93% 0.16%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 31.78% 23.14% 17.37% 16.65% 8.73% 7.69% 65.46%
Common Equity to Total Capital		 97.83% 97.44% 96.98% 96.87% 66.24% 75.59% 80.85% 81.66% 89.49% 77.85% 33.77%
Debt to EBITDA		 -0.01 -0.01 -0.01 -0.03 -0.07 -0.14 -0.04 -0.04 -0.03 -0.34 -2.76
Net Debt to EBITDA		 0.39 0.40 0.35 1.12 3.56 11.23 2.04 2.29 1.98 2.14 364.31
Long-Term Debt to EBITDA		 -0.01 -0.01 -0.01 -0.03 -0.07 -0.14 -0.04 -0.04 0.00 -0.30 -0.57
Debt to NOPAT		 -0.02 -0.02 -0.02 -0.04 -0.10 -0.09 -0.08 -0.10 -0.05 -0.83 0.39
Net Debt to NOPAT		 0.55 0.58 0.49 1.43 5.08 7.49 4.60 6.07 2.83 5.28 -51.50
Long-Term Debt to NOPAT		 -0.02 -0.02 -0.02 -0.04 -0.10 -0.09 -0.08 -0.10 0.00 -0.75 0.08
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 16.95% 15.74% 11.16% 11.06% 20.03% 17.40% 53.85%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 8.05 10 11 -3.97 -0.73 -4.78 -4.77 -3.34 -0.43 1.62 -13
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.07 0.16 0.23 0.30 0.33 0.26 0.19
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 218.40 908.67 1,322.00 2,423.00 303.18 313.50 371.20
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 5.45 4.62 3.91 3.77 5.96 9.31 6.61 6.99 6.61 7.73 20
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.10 0.20 0.38 0.45 0.41 0.29 0.21
Increase / (Decrease) in Invested Capital		 -9.76 -11 -11 3.77 0.51 4.70 2.70 3.22 0.65 -1.58 13
Enterprise Value (EV)		 2.83 2.03 10 12 22 6.74 7.56 7.60 3.85 2.73 1.44
Market Capitalization		 6.46 6.22 14 17 26 14 13 13 10 9.21 8.34
Book Value per Share		 $0.91 $0.77 $0.63 $0.60 $0.63 $0.95 $0.72 $0.76 $0.77 $0.77 $0.81
Tangible Book Value per Share		 $0.91 $0.77 $0.63 $0.60 $0.63 $0.95 $0.72 $0.76 $0.77 $0.77 $0.81
Total Capital		 5.45 4.62 3.91 3.77 5.96 9.31 6.61 6.99 6.61 7.73 20
Total Debt		 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 1.12 0.15
Total Long-Term Debt		 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.00 1.00 0.03
Net Debt		 -3.63 -4.19 -3.87 -4.70 -5.78 -9.48 -6.54 -7.06 -6.86 -7.07 -20
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 0.42 0.27 0.41 0.33 0.10 0.04 -0.06 0.05 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)		 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 1.12 0.15
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.46) ($0.15) ($0.14) ($0.09) ($0.07) ($0.02) ($0.25) ($0.02) $0.01 $0.00 $0.02
Adjusted Weighted Average Basic Shares Outstanding		 5.87M 6.01M 6.01M 6.12M 6.10M 6.90M 7.44M 7.66M 7.39M 7.80M 8.10M
Adjusted Diluted Earnings per Share		 ($0.46) ($0.15) ($0.14) ($0.09) ($0.07) ($0.02) ($0.25) ($0.02) $0.01 $0.00 $0.02
Adjusted Weighted Average Diluted Shares Outstanding		 5.87M 6.01M 6.01M 6.12M 6.10M 6.90M 7.44M 7.66M 7.39M 7.80M 8.10M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 5.87M 6.01M 6.04M 6.23M 7.44M 7.44M 7.54M 7.68M 7.80M 8.10M 8.14M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.71 -0.47 -0.41 -0.21 -0.22 0.09 -2.07 -0.12 0.16 0.03 0.21
Normalized NOPAT Margin		 0.00% 0.00% -929.09% -100.05% -53.25% 12.34% -310.99% -18.45% 27.22% 4.49% 21.82%
Pre Tax Income Margin		 0.00% 0.00% -1,865.91% -263.41% -76.07% -18.06% -301.81% -26.67% 38.89% 6.10% 31.06%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Oxbridge Re’s financial results show a significant recovery from the large losses recorded in 2023 and 2024. Revenue improved from $44,000 in Q2 2024 and $664,000 in Q2 2025 to $940,000 in Q2 2026. The latest quarter also produced $292,000 of consolidated net income and $176,000 attributable to common shareholders, compared with a $1.873 million common-shareholder loss in Q2 2025. Basic and diluted EPS increased to $0.02 from a loss of $0.25 in the year-earlier quarter.

The improvement was driven partly by a sharp reduction in expenses and the addition of $501,000 in other service-charge income. Insurance claims were zero in Q2 2026 compared with $2.293 million in Q2 2025. However, premiums earned declined to $368,000 from $582,000 a year earlier, while the company’s operating cash flow remained negative. The Q2 2026 cash-flow statement reported a $267,000 operating cash outflow, following a $210,000 inflow in Q1 2026.

The balance sheet expanded rapidly, but the increase was primarily financing-driven. Total assets rose to $20.4 million at June 30, 2026, from $8.7 million at March 31 and $9.2 million at June 30, 2025. Restricted cash accounted for $15.7 million of the latest assets. Financing activities provided $11.9 million during Q2, including $6.3 million from other financing activities, resulting in an $11.6 million increase in cash and equivalents. Investors should monitor whether this capital supports recurring insurance operations or represents a temporary financing benefit.

  • Profitability improved substantially: Q2 2026 consolidated net income was $292,000, versus losses in every quarter from Q1 2024 through Q3 2025 and only modest profits in Q4 2025 and Q1 2026.
  • Revenue momentum strengthened: Q2 2026 revenue increased approximately 51% sequentially from $623,000 in Q1 and 42% year over year from $664,000.
  • Expense control improved: Total non-interest expense fell to $647,000 in Q2 2026 from $3.614 million in the restated Q2 2025 period, when claims and salary costs were unusually high.
  • Capital and liquidity increased: Total assets reached $20.4 million, while cash and restricted cash totaled approximately $19.8 million at June 30, 2026.
  • Debt was reduced on the balance sheet: Total short- and long-term debt declined to approximately $149,000 at Q2 2026 from $1.118 million at Q1 2026, although the cash-flow data indicates substantial financing activity during the quarter.
  • Results remain dependent on nonrecurring or volatile sources: Q2 revenue included $501,000 of other service charges and $71,000 of investment gains, while premium income was only $368,000.
  • Shareholder ownership is becoming more complex: Weighted-average basic shares increased from 6.0 million in Q1 2024 to 8.1 million in Q2 2026, and redeemable noncontrolling interest rose to $12.6 million.
  • Operating cash flow remains inconsistent: Oxbridge Re generated operating cash in Q1 2026 and Q4 2025 but used $267,000 in Q2 2026; operating cash flow was also negative in Q2 2025 and much of 2024.
  • Premium production weakened: Premiums earned fell approximately 37% year over year in Q2 2026, from $582,000 to $368,000, raising questions about the durability of the latest revenue increase.
  • Financial reporting requires caution: Several historical periods, including Q1 and Q2 2025 and parts of 2024, were restated, while some cash-flow figures are marked as calculated. Investors should rely on the latest filings when comparing historical trends.
10/18/26 12:09 AM ETAI Generated. May Contain Errors.

Oxbridge Re Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Oxbridge Re's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Oxbridge Re's net income appears to be on a downward trend, with a most recent value of -$2.08 million in 2025, compared with $4 million in 2014. The previous period was -$2.59 million in 2024. Check out Oxbridge Re's forecast to explore projected trends and price targets.

Over the last 11 years, Oxbridge Re's total revenue changed from $5.56 million in 2014 to $2.58 million in 2025, a change of -53.6%.

In the past 9 quarters, Oxbridge Re's cash and equivalents has ranged from $532 thousand in Q1 2024 to $4.96 million in Q1 2025, and is currently $4.11 million as of their latest financial filing in Q2 2026.

Oxbridge Re had total debt of $118 thousand at the end of 2025, which was unchanged from 2024, and none in 2014.

Over the last 11 years, Oxbridge Re's book value per share changed from 6.12 in 2014 to 0.77 in 2025, a change of -87.4%.


Related Companies

Financial statements for NASDAQ:OXBR last updated on 8/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...
Banyan Hill Publishing | Sponsoredtc pixel
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel